Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Non-cash Items (2022 - 2026)

Kura Oncology has reported Non-cash Items over the past 5 years, most recently at $51.8 million for Q1 2026.

  • Quarterly Non-cash Items rose 9.75% to $51.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $51.8 million through Mar 2026, up 9.75% year-over-year, with the annual reading at $36.6 million for FY2025, 16.82% down from the prior year.
  • Non-cash Items was $51.8 million for Q1 2026 at Kura Oncology, up from $36.6 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $51.8 million in Q1 2026 and troughed at $6.0 million in Q4 2023.
  • The 5-year median for Non-cash Items is $45.0 million (2022), against an average of $42.7 million.
  • Year-over-year, Non-cash Items tumbled 86.66% in 2023 and then soared 638.01% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $44.7 million in 2022, then tumbled by 86.66% to $6.0 million in 2023, then soared by 638.01% to $44.0 million in 2024, then fell by 16.82% to $36.6 million in 2025, then skyrocketed by 41.53% to $51.8 million in 2026.
  • Per Business Quant, the three most recent readings for KURA's Non-cash Items are $51.8 million (Q1 2026), $36.6 million (Q4 2025), and $41.0 million (Q3 2025).